Global statistics on addictive behaviours: 2014 status report

Addiction

Volumn 110, Issue 6, 2015, Pages 904-919

  Gowing, Linda R ^a   Ali, Robert L ^a   Allsop, Steve ^b   Marsden, John ^c   Turf, Elizabeth E ^d   West, Robert ^e   Witton, John ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Addictive behaviours; Population prevalence; Public health

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; DRINKING BEHAVIOR; FEMALE; GAMBLING; GLOBAL HEALTH; HUMAN; MALE; MIDDLE AGED; PREVALENCE; SEX RATIO; SMOKING; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; FEMALE; GAMBLING; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTROPIC DRUGS; SEX DISTRIBUTION; SMOKING; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84929119189     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12899     Document Type: Article

References (22)

1. Lim S. S., Vos T., Flaxman A. D., Danaei G., Shibuya K., Adair-Rohani H. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-60 (2nd corrected version published online 12April2013).
2. Ladouceur R., Boisvert J.-M., Pepin M., Loranger M., Sylvain C. Social cost of pathological gambling. J Gambl Stud 1994; 10: 399-409.
3. Collins D., Lapsley H., Lecavalier J., Single E. Introduction: improving economic data to inform decisions in drug control. Bull Narc 2000; 52: 1-20.
4. World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2014.
5. Salomon J. A., Vos T., Hogan D. R., Gagnon M., Naghavi M., Mokdad A. et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2129-43.
6. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2014. Vienna, United Nations Office on Drugs and Crime; 2014.
7. Degenhardt L., Bucello C., Calabria B., Nelson P., Roberts A., Hall W. et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011; 117: 85-101.
8. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223-2233.
9. Roerecke M., Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 2014; 12: 182.
10. Chikritzhs T., Stockwell T., Naimi T., Andreasson S., Dangardt F., Liang W. Has the leaning tower of presumed health benefits from 'moderate' alcohol use finally collapsed? Addiction 2015; doi: 10.1111/add.12828 [E-pub ahead of print] (accessed 22 January 2015).
11. Roerecke M., Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 2013; 108: 1562-578.
12. Ng M., Freeman M. K., Fleming T. D., Robinson M., Dwyer-Lindgren L., Thomson B. et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311: 183-92.
13. World Health Organization (WHO). WHO Global Report: Mortality Attributable To Tobacco. Geneva, Switzerland: World Health Organization; 2012.
14. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
15. Degenhardt L., Chiu W.-T., Sampson N., Kessler R. C., Anthony J. C., Angermeyer M. et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLOS Med 2008; 5: e141.
16. Degenhardt L., Baxter A. J., Lee Y. Y., Hall W., Sara G. E., Johns N. et al. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend 2014; 137: 36-47.
17. Degenhardt L., Whiteford H., Hall W. D. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev 2014; 33: 4-12.
18. Degenhardt L., Whiteford H. A., Ferrari A. J., Baxter A. J., Charlson F. J., Hall W. D. et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1564-74.
19. Degenhardt L., Ferrari A. J., Calabria B., Hall W. D., Norman R. E., McGrath J. et al. The global epidemiology and contribution of cannabis use and dependence to the Global Burden of Disease: Results from the GBD 2010 Study. PLOS ONE 2013; 8: e76635.
20. Mathers B. M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S. A. et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-45.
21. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
22. Mathers B. M., Degenhardt L., Bucello C., Lemon J., Wiessing L., Hickman M., Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ 2013; 91: 102-23.